Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Caroline Hartley, a Senior Postdoctoral Research Fellow in the Paediatric Neuroimaging Group, has been awarded the highly competitive Sir Henry Dale Fellowship.

Feet of new born baby under ultraviolet lamp in the incubator

The scheme is a partnership between the Royal Society and the Wellcome Trust, and provides five years of funding for postdoctoral researchers who aim to become independent scientists leading their own groups. Dr Hartley’s research programme is focused on understanding the relationship between apnoeas and brain function in premature infants; it is due to start in 2019.


Premature infants often experience apnoeas – cessation of breathing – which can result in decreased oxygen supply to the brain. Yet whether this impacts brain development is unclear. The aim of Caroline's Fellowship is to gain a better understanding of the interaction between brain activity and apnoeas in premature infants in both the immediate and long-term, with the ultimate aim of improving outcomes for prematurely-born children.


I am truly honoured to be awarded this Fellowship and very excited to have the opportunity to investigate these fascinating and clinically relevant questions. Current rapid advances in technology will allow me to harness new developments and derive novel tools to obtain a comprehensive picture of preterm development, which I hope will lead to improved treatment for some of the most vulnerable members of our society" - said Dr Hartley.














Professor Rebeccah Slater, the head of the Paediatric Neuroimaging Group, commented on the Fellowship: "Caroline's award of a Sir Henry Dale Fellowship is a fantastic personal achievement. Supporting postdocs making the transition to establishing their independent academic careers is one of the most rewarding aspects of my job, and I am delighted that Caroline will remain in our department to further build paediatric neuroscience research at Oxford."

The Department of Paediatrics' ongoing commitment to support early careers researchers has recently been recognised with an Athena SWAN Silver Award. "This fellowship is in recognition of  Caroline’s outstanding scientific contributions at this early stage of what is without a doubt a promising career. In the name of the entire Department of Paediatrics, I wish her the very best" said Professor Georg Hollander, the Head of Department.

Read more about the research of the Paediatric Neuroimaging Group.

Similar stories

University spinout PepGen awarded major financing to target Duchenne muscular dystrophy

Awards & Appointments Neuromuscular Diseases

PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.

Children’s pain ‘swept under the carpet for too long’ – Lancet Commission

Neuroimaging Publication Research

The launch of Lancet Child and Adolescent Health Commission - the first ever to address paediatric pain - aims to raise the profile of children’s pain from early years to early adulthood.

Enriching Engagement (Round 2) awardees announced

Awards & Appointments Neuromuscular Diseases Public Engagement

The awardees for the second round of the University of Oxford’s Enriching Engagement funding scheme have now been announced, including a project from Paediatrics.

Typhoid vaccine project wins Vice-Chancellor award

Awards & Appointments Vaccinology

Congratulations to Professor Andrew Pollard who is the Winner of the Policy Engagement category in the Vice-Chancellor Innovation Awards 2020 for his work on Global policy on typhoid vaccines through research at Oxford!

Oxford COVID-19 vaccine begins human trial stage

COVID-19 Recruitment Research Vaccinology

University of Oxford researchers have begun testing a COVID-19 vaccine in human volunteers in Oxford today. Around 1,110 people will take part in the trial, half receiving the vaccine and the other half (the control group) receiving a widely available meningitis vaccine.

Paediatrics project receives funding to assess novel coronavirus infection rates in children and teenagers across the UK

Awards & Appointments COVID-19 Vaccinology

A multi-site project, called ‘What’s the STORY?’ has received funding from UK Research and Innovation (UKRI) to assess novel coronavirus infection rates in children and teenagers across the UK. Given the importance of this study to the national Covid-19 response it has been deemed a priority study for the National Institute for Health Research’s (NIHR) Urgent Public Health Response.